Back

Low cellular fibronectin levels are associated with bleeding in patients with atrial fibrillation: a long-term observational study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Kinga Gladys

Jagiellonian University Medical College, Cracow (Poland)

7 More presentations in this session

Presentation thumbnail
MicroRNA signatures in diabetes and myocardial infarction: in silico prediction and bench-to-bedside analysis
Ms S. Ahmadova (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Kynurenine is a prognostic biomarker in pulmonary infections with association to cardiac dysfunction
Doctor A. Puetz (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Large-scale protein-disease risk association analysis in the UK Biobank
Assistant Professor S. Chlamydas (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Examining the predictive value of plasma lysozyme for future all-cause mortality
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Integrated Impact of hs-CRP, LDL-C and Lp(a) on Platelet Reactivity in Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy
Ms J. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Altered fibrin clot properties and elevated von Willebrand Factors level are associated with progression to permanent atrial fibrillation during follow-up: a cohort study
thumbnail
Congress Presentation
Clinical determinants of blood biomarkers of atrial cardiomyopathy: results from the ISOLATION AF ablation cohort study.
thumbnail
Congress Presentation
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources